4-methoxy-3-thiophen-2-yl-benzoic acid | 868265-69-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-methoxy-3-thiophen-2-yl-benzoic acid
• 英文别名: 4-methoxy-3-thiophen-2-ylbenzoic acid；4-Methoxy-3-(thiophen-2-YL)benzoic acid
• CAS: 868265-69-4
• 化学式: C₁₂H₁₀O₃S
• 分子量: 234.276
• InChiKey: DILRLAGJPQGWAL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  74.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-methoxy-3-thiophen-2-yl-benzoic acid 、 N-甲基-N-甲氧基胺盐酸盐 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 21.25h， 以41%的产率得到4,N-dimethoxy-N-methyl-3-thiophen-2-ylbenzamide
  参考文献：
  名称：

  [EN] 2-ARYLOXYETHYL GLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS
  [FR] DERIVES DE LA 2-ARYLOXYETHYL GLYCINE ET LEUR UTILISATION COMME INHIBITEURS DU TRANSPORT DE LA GLYCINE

  摘要：

  本发明涉及某些2-芳氧基乙基甘氨酸衍生物，它们作为甘氨酸类型-1转运体的抑制剂具有活性，涉及含有它们的药物组合物，以及它们在治疗神经学和神经精神障碍中的用途。

  公开号：

  WO2005100301A1
• 作为产物：
  描述：

  2-甲氧基-5-甲氧羰基苯基硼酸 在 四(三苯基膦)钯 、 水 、 sodium carbonate 、 lithium hydroxide 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 4-methoxy-3-thiophen-2-yl-benzoic acid
  参考文献：
  名称：

  Synthesis and biological evaluation of salicylate-based compounds as a novel class of methionine aminopeptidase inhibitors

  摘要：

  A series of salicylate-based compounds were designed and synthesized based on the simple function group replacement from our previously reported catechol-containing inhibitors of methionine aminopeptidase (MetAP). Some of these salicylate derivatives showed similar potency and metalloform selectivity, and some showed considerable antibacterial activity. These findings are consistent with our previous conclusion that Fe(II) is the likely metal used by MetAP in bacterial cells and provide new lead structures that can be further developed as novel antibacterial agents. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.09.080

文献信息

• 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
  申请人：Weingarten David M.

  公开号：US20060063828A1

  公开（公告）日：2006-03-23

  The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.

  本发明涉及一般式化合物、药物组合物及其使用方法，或其药学上可接受的盐或酯，其中取代基在申请中有定义。
• [EN] 1,2-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND PHARMACEUTICAL COMPOSITIONS THEREOF<br/>[FR] 1,2-BIS-(PHENYL-SUBSTITUE)-2-PROPEN-1-ONES ET DES COMPOSITIONS PHARMACEUTIQUES EN CONTENANT
  申请人：ATHEROGENICS INC

  公开号：WO2006004903A3

  公开（公告）日：2006-05-04
• [EN] 2-ARYLOXYETHYL GLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS<br/>[FR] DERIVES DE LA 2-ARYLOXYETHYL GLYCINE ET LEUR UTILISATION COMME INHIBITEURS DU TRANSPORT DE LA GLYCINE
  申请人：LILLY CO ELI

  公开号：WO2005100301A1

  公开（公告）日：2005-10-27

  The present invention relates to certain 2-aryloxyethyl glycine derivatives that exhibit activity as inhibitors of the glycine type-1 transporter, to pharmaceutical compositions containing them and to their use in the treatment of neurological and neuropsychiatric disorder.

  本发明涉及某些2-芳氧基乙基甘氨酸衍生物，它们作为甘氨酸类型-1转运体的抑制剂具有活性，涉及含有它们的药物组合物，以及它们在治疗神经学和神经精神障碍中的用途。
• Synthesis and biological evaluation of salicylate-based compounds as a novel class of methionine aminopeptidase inhibitors
  作者：Wen-Long Wang、Sergio C. Chai、Qi-Zhuang Ye

  DOI：10.1016/j.bmcl.2011.09.080

  日期：2011.12

  A series of salicylate-based compounds were designed and synthesized based on the simple function group replacement from our previously reported catechol-containing inhibitors of methionine aminopeptidase (MetAP). Some of these salicylate derivatives showed similar potency and metalloform selectivity, and some showed considerable antibacterial activity. These findings are consistent with our previous conclusion that Fe(II) is the likely metal used by MetAP in bacterial cells and provide new lead structures that can be further developed as novel antibacterial agents. (C) 2011 Elsevier Ltd. All rights reserved.